Using an epigenetic mechanism, romidepsin restored gene expression and alleviated social deficits in animal model of autism
Of all the challenges that come with a diagnosis of autism spectrum disorder (ASD), the social difficulties are among the most devastating. Currently, there is no treatment for this primary symptom of ASD. New research at the University at Buffalo reveals the first evidence that it may be possible to use a single compound to alleviate the behavioral symptoms by targeting sets of genes involved in the disease.
The research, published today in Nature Neuroscience, demonstrated that brief treatment with a very low dose of romidepsin, a Food and Drug Administration-approved anti-cancer drug, restored social deficits in animal models of autism in a sustained fashion.
The three-day treatment reversed social deficits in mice deficient in a gene called Shank 3, an important risk factor for ASD. This effect lasted for three weeks, spanning the juvenile to late adolescent period, a critical developmental stage for social and communication skills. That is equivalent to several years in humans, suggesting the effects of a similar treatment could potentially be long-lasting, the researchers say.
Profound, prolonged effect
“We have discovered a small molecule compound that shows a profound and prolonged effect on autism-like social deficits without obvious side effects, while many currently used compounds for treating a variety of psychiatric diseases have failed to exhibit the therapeutic efficacy for this core symptom of autism,” said Zhen Yan, PhD, professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, and senior author on the paper.
The study builds on her previous research from 2015. That work revealed how the loss of Shank 3 disrupts neuronal communications by affecting the function of the NMDA (n-methyl-D-aspartate) receptor, a critical player in regulating cognition and emotion, leading to deficits in social preference that are common in ASD.
In the new research, the UB scientists found they could reverse those social deficits with a very low dose of romidepsin, which, they found, restores gene expression and function using an epigenetic mechanism, where gene changes are caused by influences other than DNA sequences. Yan noted that human genetics studies have suggested that epigenetic abnormalities likely play a major role in ASD.
To pursue these promising findings, Yan has founded a startup company called ASDDR, which was awarded a Small Business Technology Transfer grant from the National Institutes of Health last summer for more than $770,000.
Epigenetics in ASD
Many of the mutations in ASD, Yan explained, result from chromatin remodeling factors, which are involved in dynamically changing the structure of chromatin, the complex of genetic material in the cell nucleus that condenses into chromosomes.
“The extensive overlap in risk genes for autism and cancer, many of which are chromatin remodeling factors, supports the idea of repurposing epigenetic drugs used in cancer treatment as targeted treatments for autism,” said Yan.
She and her colleagues knew that chromatin regulators — which control how genetic material gains access to a cell’s transcriptional machinery — were key to treating the social deficits in ASD, but the challenge was to know how to affect key risk factors at once.
“Autism involves the loss of so many genes,” Yan explained. “To rescue the social deficits, a compound has to affect a number of genes that are involved in neuronal communication.”
To do so, the team turned to a type of chromatin remodeler called histone modifiers. They modify proteins called histones that help organize genetic material in the nucleus so gene expression can be regulated. Since many genes are altered in autism, the UB scientists knew a histone modifier might be effective.
Loosening up chromatin
In particular, they were interested in histone deacetylase (HDAC), a family of histone modifiers that are critically involved in the remodeling of chromatin structure and the transcriptional regulation of targeted genes.
“In the autism model, HDAC2 is abnormally high, which makes the chromatin in the nucleus very tight, preventing genetic material from accessing the transcriptional machinery it needs to be expressed,” said Yan. “Once HDAC2 is upregulated, it diminishes genes that should not be suppressed, and leads to behavioral changes, such as the autism-like social deficits.”
But the anti-cancer drug romidepsin, a highly potent HDAC inhibitor, turned down the effects of HDAC2, allowing genes involved in neuronal signaling to be expressed normally.
“The HDAC inhibitor loosens up the densely packed chromatin so that the transcriptional machinery gains access to the promoter area of the genes; thus they can be expressed,” Yan said.
The rescue effect on gene expression was widespread. When Yan and her co-authors conducted genome-wide screening at the Genomics and Bioinformatics Core at UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, they found that romidepsin restored the majority of the more than 200 genes that were suppressed in the autism animal model they used.
“The advantage of being able to adjust a set of genes identified as key autism risk factors may explain the strong and long-lasting efficacy of this therapeutic agent for autism,” Yan explained. She and her colleagues will continue their focus on discovering and developing better therapeutic agents for autism.
The Latest on: Autism
- Autism Speaker Series presenting nationally known speaker Kerry Magro on Feb. 26 on December 17, 2018 at 7:43 am
The Autism Center at Misericordia University's fourth annual Autism Speaker Series is presenting award-winning motivational speaker and best-selling author Kerry Magro who is on the autism spectrum fo... […]
- miRNA Cluster Study Suggests Potential New Therapies for Autism and Schizophrenia on December 17, 2018 at 6:32 am
Scientists say they have discovered a microRNA (miRNA) cluster that regulates synaptic strength and is involved in the control of social behavior in mammals. The researchers believe their discovery ma... […]
- Detroit Teen With Autism Reported Missing on December 17, 2018 at 6:26 am
DETROIT, MI — Detroit police are searching for a missing 15-year-old teen who has autism. Police say Noah Walton was last seen by his sister at their home in the 4200 block of Wavely around 2:30 ... […]
- 15-year-old Detroit teen with autism is reported missing on December 17, 2018 at 6:18 am
Detroit police are searching for a missing 15-year-old teen. Noah Walton was last seen by his sister at their home in the 4200 block of Wavely around 2:30 p.m. Sunday. When his sister went to go check ... […]
- Children With Severe Autism Excluded From Research on December 17, 2018 at 5:59 am
One of the first studies of its kind has concluded that children with more severe levels of autism spectrum disorder (ASD) are increasingly being excluded from research, a finding, investigators say, ... […]
- What My Son With Autism Taught Me About Being A CEO on December 17, 2018 at 5:00 am
Chief Servant Officer of CEO Experience. CXP produces the monthly CEO Executive Guide designed for CEOs.Message me to get your free copy. Things don't always go as planned. My life and leadership styl... […]
- Why I Will Fight for My Autism Diagnosis on December 17, 2018 at 12:25 am
“Has anyone ever considered whether you could have Asperger’s syndrome?” As I sat in my doctor’s office at the age of 24, this was the last thing I had anticipated them saying — and yet it somehow fit ... […]
- ‘Sensitive’ Santa in Orange brings joy to kids on autism spectrum on December 16, 2018 at 4:47 pm
ORANGE — Far away from the stressful, maddening lines, crowds, noise and bright lights of the mall Sunday, children on the autism spectrum visited a “sensitive” Santa, asking for everything from black ... […]
- Revisiting Adam Lanza and autism, six years after Sandy Hook on December 16, 2018 at 6:00 am
Shortly after the 2012 Sandy Hook Elementary School shooting, someone very close to me became upset after one of her co-workers made a comment disparaging autistic people. The shooter in that case was ... […]
- Researchers uncover molecular mechanisms linked to autism and schizophrenia on December 15, 2018 at 2:08 pm
Studies have linked DNA changes to their molecular effects in the brain, uncovering new mechanisms for psychiatric diseases. The findings provide a roadmap for developing a new generation of therapies ... […]
via Google News and Bing News